Articles published by REVEAL GENOMICS

REVEAL GENOMICS Aligns Founder Leadership With Priorities to Support Long-term Growth, Scientific Excellence, and Global Partnerships

Today 7:43 EST

From REVEAL GENOMICS

Via Business Wire

SABCS 2025: REVEAL GENOMICS Presents Major Advance in Predicting Brain Metastasis in HER2+ Breast Cancer

December 08, 2025

From Reveal Genomics

Via Business Wire

REVEAL GENOMICS and Ona Therapeutics Join Forces to Advance Next-generation Cancer Treatment

April 14, 2025

From REVEAL GENOMICS

Via Business Wire

REVEAL GENOMICS® and the Istituto Europeo di Oncologia (IEO) Collaborate on a Groundbreaking HER2DX® Test Decision Impact Study

December 03, 2024

From REVEAL GENOMICS

Via Business Wire

REVEAL GENOMICS® Unveils TNBCDX®: the First Genomic Test Designed for Early-stage Triple-Negative Breast Cancer

September 12, 2024

From REVEAL GENOMICS

Via Business Wire

Reveal Genomics® HER2DX® Genomic Test Demonstrates Significant Potential in HER2-Positive Advanced Gastric Cancer

June 27, 2024

From Reveal Genomics

Via Business Wire

Reveal Genomics® to Evaluate Prospective Real-time Performance of HER2DX® Genomic Test in the United States

June 18, 2024

From Reveal Genomics

Via Business Wire

SABCS23: Reveal Genomics® Unleashes Groundbreaking DNADX® Liquid Biopsy Data for Metastatic Breast Cancer

December 04, 2023

From REVEAL GENOMICS

Via Business Wire

REVEAL GENOMICS®´ Breakthrough Technology Enters the Liquid Biopsy Field in Oncology

March 09, 2023

From REVEAL GENOMICS

Via Business Wire

HER2DX® Recognized by TIME as One of the Best Inventions of 2022

November 10, 2022

From REVEAL GENOMICS

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.